Opinions diverge on how best to approach this problem while also preserving access and innovation, but small molecule generic ... the existing PRV program solely incentivizes development and ...

Ultimately, a more accessible program will stimulate the development of more complex generic drug products, leading to multiple in-market treatment options and healthy competition, with downward ...

It is designed for use by biopharmaceutic, formulation, and CMC scientists to aid in formulating complex novel and generic small ... its applications in clinical development, including prediction ...

This paper examines a specific market – limited or no competition small molecule generic ... boon to drug development and product market entry, Congress has expanded the PRV program twice ...